Three insights:
1. VIA Disc, from Vivex Biomedical, is a non-surgical, minimally invasive procedure to repair damaged discs resulting from degenerative disc disease.
2. The study examined the performance and safety of the VIA Disc in 224 patients.
3. The procedure involves delivering the viable allograft into a diseased disc to combat chronic lower back pain.
“I am highly encouraged by the provisional results and safety data,” said Douglas Beall, MD, principal investigator of the study. “Interventions like VIA Disc have the potential for treating moderate degenerative discs and greatly advance the alternatives to surgical intervention.”
More articles on devices:
Smith & Nephew launch implant for hip fractures — 3 insights
2019 Medtech Breakthrough awards honors 3 orthopedic companies
Orthopedic surgeon whistleblower receives big award in Biomet kickback case & more: 8 device company notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
